IBM Rhapsody DM 4.0/5.0/6.0 xml external entity reference
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.2 | $0-$5k | 0.00 |
Summary
A vulnerability identified as critical has been detected in IBM Rhapsody DM 4.0/5.0/6.0. The impacted element is an unknown function. This manipulation causes xml external entity reference. This vulnerability is registered as CVE-2016-8974. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability was found in IBM Rhapsody DM 4.0/5.0/6.0. It has been declared as critical. Affected by this vulnerability is some unknown functionality. The manipulation with an unknown input leads to a xml external entity reference vulnerability. The CWE definition for the vulnerability is CWE-611. The product processes an XML document that can contain XML entities with URIs that resolve to documents outside of the intended sphere of control, causing the product to embed incorrect documents into its output. As an impact it is known to affect confidentiality. The summary by CVE is:
IBM Rhapsody DM 4.0, 5.0 and 6.0 is vulnerable to a denial of service, caused by an XML External Entity Injection (XXE) error when processing XML data. A remote attacker could exploit this vulnerability to expose highly sensitive information or consume all available memory resources. IBM Reference #: 1997798.
The bug was discovered 02/07/2017. The weakness was published 02/23/2017 (Website). The advisory is shared at ibm.com. This vulnerability is known as CVE-2016-8974 since 10/25/2016. The attack can be launched remotely. A single authentication is required for exploitation. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $0-$5k at the moment (estimation calculated on 09/02/2020). It is expected to see the exploit prices for this product increasing in the near future.
The vulnerability was handled as a non-public zero-day exploit for at least 16 days. During that time the estimated underground price was around $5k-$25k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.2VulDB Meta Temp Score: 6.2
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 8.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Xml external entity referenceCWE: CWE-611 / CWE-610
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
10/25/2016 🔍02/07/2017 🔍
02/23/2017 🔍
02/23/2017 🔍
02/23/2017 🔍
09/02/2020 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2016-8974 (🔍)
GCVE (CVE): GCVE-0-2016-8974
GCVE (VulDB): GCVE-100-97225
OSVDB: - CVE-2016-8974 - IBM - Rhapsody DM - XML External Entity Injection Issue
Entry
Created: 02/23/2017 21:08Updated: 09/02/2020 12:37
Changes: 02/23/2017 21:08 (57), 09/02/2020 12:37 (3)
Complete: 🔍
Cache ID: 216:E7E:103
No comments yet. Languages: en.
Please log in to comment.